Data from the Diabetes Control and Complications Trial showed an increased risk of severe hypoglycaemia and excessive weight gain with intensive insulin therapy highlighting the necessity for interventions that achieve glycaemic control without reliance on large insulin doses [43–45]. Here, INS is linked to diabetes mellitus.